Figure 6.

Evaluation of microRNAs in Plasma as Novel Biomarkers for FM

(A) The ROC curve for miR-4763-3p in FM patients. (B) The ROC curve for miR-4281 in FM patients. (C) The ROC curve for miR-4281 in MI patients. (D) The expression of miR-4763-3p and miR-4281 was detected by quantitative real-time PCR in the plasma of rheumatic heart disease patients with acute heart failure (∗p < 0.05 versus control). (E) The correlation between circulating miR-4763-3p level and myocardial edema area (N = 9). (F) The correlation between circulating miR-4281 level and myocardial edema area (N = 9).